Page 3 - Adpt News Today

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.33) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.33), Briefing.com reports. The firm had revenue of $48.93 million during the quarter, compared to the consensus estimate of $44.87 million. Adaptive Biotechnologies had a […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.33) EPS for the quarter, meeting analysts’ consensus estimates of ($0.33), Briefing.com reports. Adaptive Biotechnologies had a negative return on equity of 41.21% and a negative net margin of 105.87%. The firm had revenue of $48.93 million for […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.33) EPS for the quarter, meeting the consensus estimate of ($0.33), Briefing.com reports. Adaptive Biotechnologies had a negative net margin of 100.69% and a negative return on equity of 41.63%. The business had revenue of $48.93 million during […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) dropped 4.9% during trading on Wednesday . The company traded as low as $6.35 and last traded at $6.35. Approximately 257,624 shares changed hands during trading, a decline of 73% from the average daily volume of 964,725 shares. The stock had previously closed at $6.68. Analyst Upgrades and […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) CFO Tycho Peterson sold 38,000 shares of Adaptive Biotechnologies stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $7.16, for a total transaction of $272,080.00. Following the completion of the transaction, the chief financial officer now directly owns 454,891 shares […]

Platinum Investment Management Ltd. lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 39.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 366,230 shares of the company’s stock after buying an additional 102,739 shares during the quarter. […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) CFO Tycho Peterson sold 38,000 shares of Adaptive Biotechnologies stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $7.16, for a total value of $272,080.00. Following the sale, the chief financial officer now owns 454,891 shares in the company, valued […]

Jennison Associates LLC increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 11.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 195,036 shares of the company’s stock after acquiring an additional 20,745 shares during the period. Jennison Associates LLC […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price lifted by Piper Sandler from $14.00 to $15.00 in a report released on Monday morning, The Fly reports. A number of other analysts also recently issued reports on ADPT. Credit Suisse Group reiterated an underperform rating and issued a $7.00 price target on shares of […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) – Investment analysts at William Blair lifted their Q2 2023 earnings estimates for Adaptive Biotechnologies in a report issued on Thursday, May 4th. William Blair analyst A. Brackmann now forecasts that the company will post earnings of ($0.31) per share for the quarter, up from their previous estimate […]